The Globe and Mail

Cue Health Receives FDA Emergency Use Authorization for Molecular Mpox Test

Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced it has received Emergency Use Authorization (EUA) from the United States Food and Drug Administration (FDA) for its ...
Stockhouse

Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use

The test will be designed to detect and differentiate between the four viruses and deliver results in approximately 25 minutes Cue Health (Nasdaq: HLTH), a healthcare technology company, today ...
Yahoo Finance

Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test

SAN DIEGO, June 12, 2020 (GLOBE NEWSWIRE) -- Cue Health Inc. (“Cue”), a healthcare technology company, announced today that it has received Emergency Use Authorization (“EUA”) from the U.S. Food and ...
MobiHealthNews

Cue Health receives first-ever de novo authorization for at-home COVID-19 test

Home diagnostics company Cue Health announced its received FDA de novo authorization for its at-home COVID-19 test, dubbed the Cue COVID-19 Molecular Test. The Cue COVID-19 Molecular Test detects ...
Stockhouse

Cue Health Taps Cardinal Health to Distribute its Pioneering Molecular COVID-19 Tests

SAN DIEGO and DUBLIN, Ohio, Feb. 17, 2022 /PRNewswire/ -- Today Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company, and Cardinal Health (NYSE: CAH) announced expanded distribution of ...
Yahoo Finance

Cue Launches Revolutionary Consumer Health Device for Tracking Health at the Molecular Level

SAN DIEGO, CA--(Marketwired - May 13, 2014) - Cue®, a technology company creating consumer health products, today introduced Cue, a revolutionary device for tracking health information at the ...